Search results for: 'pfas of care testing part market'

21 Sep 2022  |  North America  |  Market Research

Drinking Water PFAS Treatment—United States: Forecast to 2026

Future Growth Potential of Sample Testing to Help Map the Presence of PFAS

Infographics

×

Growing concerns regarding the presence of perfluoroalkyl and polyfluoroalkyl substances (PFAS) in surface water, groundwater, wastewater, soil, and air are making state and national level regulations in the United States regarding permissible contaminant limits more stringent. There are growing efforts among municipal utilities and different indus...

Smartphone-based point-of-care (POC) diagnostics are rapidly emerging as medical diagnostics, enabling remote or self-monitoring tools for general wellness and a range of health conditions. Smartphones enable low-cost, rapid, and handy POC diagnostics. Intrinsic sensors of smartphones or extrinsic sensing devices working with intelligent data analy...

The global POCT market is rapidly evolving from standalone rapid diagnostics to connected, AI-enabled clinical intelligence ecosystems that support decentralized healthcare delivery. Growth is driven by the increasing demand for faster clinical decision-making, early disease detection, personalized treatment, and expanded access to testing across h...

PFAS are highly persistent in the environment and are associated with a wide range of serious health risks, resulting in increasing demand for effective management solutions. This study offers a comprehensive analysis of the drinking water PFAS management industry in the United States, highlighting important growth drivers and restraints. The ne...

This study provides an overview of the global point-of-care testing (POCT) industry, which refers to any routine or specialized lab pathology testing conducted rapidly, on-site/near the site of the patient, where care or treatment is provided. COVID-19 radicalization is changing the global diagnostics landscape. Consolidation trends, structural s...

01 Jul 2016  |  Europe  |  Market Research

Western Europe Point-of-Care Testing (POCT) Market

Infographics

×

Point-of-care testing is an integral part of the IVD market that is rapidly evolving into a preferred testing mode in the EU region. POCT is a segment that presents growth opportunities for a cross-section of players, ranging from OEMs to data integrators to technology vendors. The stakeholders need to be abreast of the challenges posed by the indu...

The global hemoglobin A1C (HbA1c) testing market will witness significant growth driven by technological advances and the increasing adoption of point-of-care testing (POCT). Real-time glucose monitoring and conventional HbA1c testing have been integrated, revolutionizing patient care by offering better treatment choices and better results. By stre...

This research service offers a comprehensive analysis of the global genetic testing industry (specifically, germline genetic testing, which analyzes inherited genetic variations present in an individual from birth and can be passed to offspring). The industry growth is driven by a shift towards preventive care, rising maternal ages, increasing gove...

Since the onset of the COVID-19 pandemic, molecular diagnostics mergers/acquisition transactions and product launches for infectious disease testing are indicating a pivot toward a new direction or an enhancement of portfolios. The emergence of saliva sample testing and the transition to PCR-based syndromic and direct-to-consumer testing for respir...